Technical / White Paper

Elemental Impurity Analysis in Pharmaceuticals – The Road To Implementation of ICH Q3D

15 DEC 2015 Tuesday

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Butterworth, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

The International Conference of Harmonisation (ICH) guidance document on elemental impurities, Q3D, reached step 4 in December 2014, meaning the final draft is recommended for adoption. This paper outlines the key timeframes for implementation in the EU and US and considerations for ensuring compliance.

Related resources from Butterworth

Excellence in Pharmaceutical Analysis
Enhanced Sampling and Calibration Procedures for the Analysis of Residual Oxygen in Nitrogen Purged Pharmaceutical Packaging by GC-TCD
Enhanced Residual Solvents Analysis: A Practical Approach to Sampling, Delivery, Storage and Analysis.
A Method to Meet the New Ph Eur Ninhydrin-Positive Substances Requirement

Elemental Impurity Analysis in Pharmaceuticals – The Road To Implementation of ICH Q3D

Related resources from Butterworth

Supplier info centre

For more product information visit Butterworth's information centre

Outsourcing-Pharma

Resources